Good practices and common pitfalls on advertising of medicines in Italy

Giulio Coraggio
Giulio CoraggioLawyer | Partner @DLA Piper, Head of Technology (Italy) | Top IoT Global Influencer | Privacy | Fintech | Gaming at DLA Piper

The presentation relates to the advertising of medicines under the laws of Italy and was drafted by the lawyer, Nicola Landolfi, of the international law firm DLA Piper.

#4 Good practices
and common pitfalls on
promotion of medicines in Italy
Advertising in Italy: DOs and DON'Ts
·Promote to healthcare professionals all kinds of authorized medicines
·Request the authorization for promotional materials addressed to the
general public
·File with the Italian Medicines Agency (AIFA) promotional materials
addressed to healthcare professionals
Efficacy Claims General Rules
·Promote medicines that have not been granted a marketing authorization
·Do any misleading promotion
·Promote exclusively or principally at children
Content of the
promotional message
·Include information compliant with the summary of product characteristics
·Encourage the rational use of the medicinal product, by presenting it
objectively and without exaggerating its properties
·Make it clear that the message is an advertisement
·Clearly identify the product as a medicinal product
·Distribute samples of medicinal products
·Promote prescription-only medicines
·Promote reimbursed medicines
·Promote medicinal products containing narcotics
·Promote products intended for use with the intervention of HCPs
·Use claims that can lead to excessive, improper or inappropriate use of
medicinal products
When addressing the
general public

Recommended

Promotional activities of pharmaceutical industry by
Promotional activities of pharmaceutical industryPromotional activities of pharmaceutical industry
Promotional activities of pharmaceutical industryAbdu Nasir H
1.3K views11 slides
Presentation: Advertising cosmetic injectables - Complying with the therapeut... by
Presentation: Advertising cosmetic injectables - Complying with the therapeut...Presentation: Advertising cosmetic injectables - Complying with the therapeut...
Presentation: Advertising cosmetic injectables - Complying with the therapeut...TGA Australia
1.4K views17 slides
11-Drug-advertisement.ppt by
11-Drug-advertisement.ppt11-Drug-advertisement.ppt
11-Drug-advertisement.pptRajatJain353720
13 views24 slides
Good practices and common pitfalls on advertising of medical devices in Italy by
Good practices and common pitfalls on advertising of medical devices in ItalyGood practices and common pitfalls on advertising of medical devices in Italy
Good practices and common pitfalls on advertising of medical devices in ItalyGiulio Coraggio
870 views5 slides
Teresa alves - selling sickness 2010 by
Teresa alves -  selling sickness 2010Teresa alves -  selling sickness 2010
Teresa alves - selling sickness 2010Gezonde scepsis
1.8K views32 slides
Med counterfiet by
Med counterfietMed counterfiet
Med counterfietsuneseal
1K views12 slides

More Related Content

Similar to Good practices and common pitfalls on advertising of medicines in Italy

Health economics pharma lab ppt by
Health economics pharma lab pptHealth economics pharma lab ppt
Health economics pharma lab pptTon Mausisa
2.7K views72 slides
Off-label Use of Medications for COVID-19 Treatment by
Off-label  Use of Medications for COVID-19 Treatment Off-label  Use of Medications for COVID-19 Treatment
Off-label Use of Medications for COVID-19 Treatment Belachew Weldegebriel
460 views36 slides
Off-label and Compassionate use of Medications for COVID-19 Treatment by
Off-label and Compassionate use of Medications for COVID-19 Treatment Off-label and Compassionate use of Medications for COVID-19 Treatment
Off-label and Compassionate use of Medications for COVID-19 Treatment Belachew Weldegebriel
347 views34 slides
Strategic Management presentation for a Pharmaceutical Industry by
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryEngr. Carlo Senica, MBA, CPSM
12.1K views50 slides

Similar to Good practices and common pitfalls on advertising of medicines in Italy(20)

Health economics pharma lab ppt by Ton Mausisa
Health economics pharma lab pptHealth economics pharma lab ppt
Health economics pharma lab ppt
Ton Mausisa2.7K views
Off-label and Compassionate use of Medications for COVID-19 Treatment by Belachew Weldegebriel
Off-label and Compassionate use of Medications for COVID-19 Treatment Off-label and Compassionate use of Medications for COVID-19 Treatment
Off-label and Compassionate use of Medications for COVID-19 Treatment
Introduction to pharmacovigilance by Nahla Amin
Introduction to pharmacovigilanceIntroduction to pharmacovigilance
Introduction to pharmacovigilance
Nahla Amin36.9K views
communitypharmacy ppt.pdf by ShikhaSachde
communitypharmacy ppt.pdfcommunitypharmacy ppt.pdf
communitypharmacy ppt.pdf
ShikhaSachde166 views
Quality assurance process final by Kshitiz Thapa
Quality assurance process finalQuality assurance process final
Quality assurance process final
Kshitiz Thapa398 views
Chapter 8_Over The Counter (OTC) Medications.pptx by VinayGaikwad14
Chapter 8_Over The Counter (OTC) Medications.pptxChapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptx
VinayGaikwad141.7K views
Concept of essential medicines and rational use of medicines by Vivek Nayak
Concept of essential medicines and rational use of medicinesConcept of essential medicines and rational use of medicines
Concept of essential medicines and rational use of medicines
Vivek Nayak2.2K views
Pharmacy professional ethics - in INDIA by Abith Baburaj
Pharmacy professional  ethics - in INDIAPharmacy professional  ethics - in INDIA
Pharmacy professional ethics - in INDIA
Abith Baburaj785 views
Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go... by TGA Australia
Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go...Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go...
Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go...
TGA Australia983 views
Pharmacist in public health npw ppt by Sai Datri Arige
Pharmacist in public health   npw pptPharmacist in public health   npw ppt
Pharmacist in public health npw ppt
Sai Datri Arige31.2K views

More from Giulio Coraggio

Come conformarsi al Regolamento DORA sulla cybersecurity by
Come conformarsi al Regolamento DORA sulla cybersecurityCome conformarsi al Regolamento DORA sulla cybersecurity
Come conformarsi al Regolamento DORA sulla cybersecurityGiulio Coraggio
285 views1 slide
Direttiva NIS2 - Nuovi obblighi legali di cybersecurity by
Direttiva NIS2 - Nuovi obblighi legali di cybersecurityDirettiva NIS2 - Nuovi obblighi legali di cybersecurity
Direttiva NIS2 - Nuovi obblighi legali di cybersecurityGiulio Coraggio
611 views2 slides
Decreti di adeguamento ai regolamenti MDR e IVDR by
Decreti di adeguamento ai regolamenti MDR e IVDRDecreti di adeguamento ai regolamenti MDR e IVDR
Decreti di adeguamento ai regolamenti MDR e IVDRGiulio Coraggio
60 views4 slides
Nuove normativa sulla accessibilità applicabili a qualsiasi sito web by
Nuove normativa sulla accessibilità applicabili a qualsiasi sito webNuove normativa sulla accessibilità applicabili a qualsiasi sito web
Nuove normativa sulla accessibilità applicabili a qualsiasi sito webGiulio Coraggio
196 views3 slides
New Italian rules on accessibility of websites by
New Italian rules on accessibility of websitesNew Italian rules on accessibility of websites
New Italian rules on accessibility of websitesGiulio Coraggio
323 views3 slides
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022 by
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022Giulio Coraggio
552 views15 slides

More from Giulio Coraggio(20)

Come conformarsi al Regolamento DORA sulla cybersecurity by Giulio Coraggio
Come conformarsi al Regolamento DORA sulla cybersecurityCome conformarsi al Regolamento DORA sulla cybersecurity
Come conformarsi al Regolamento DORA sulla cybersecurity
Giulio Coraggio285 views
Direttiva NIS2 - Nuovi obblighi legali di cybersecurity by Giulio Coraggio
Direttiva NIS2 - Nuovi obblighi legali di cybersecurityDirettiva NIS2 - Nuovi obblighi legali di cybersecurity
Direttiva NIS2 - Nuovi obblighi legali di cybersecurity
Giulio Coraggio611 views
Decreti di adeguamento ai regolamenti MDR e IVDR by Giulio Coraggio
Decreti di adeguamento ai regolamenti MDR e IVDRDecreti di adeguamento ai regolamenti MDR e IVDR
Decreti di adeguamento ai regolamenti MDR e IVDR
Giulio Coraggio60 views
Nuove normativa sulla accessibilità applicabili a qualsiasi sito web by Giulio Coraggio
Nuove normativa sulla accessibilità applicabili a qualsiasi sito webNuove normativa sulla accessibilità applicabili a qualsiasi sito web
Nuove normativa sulla accessibilità applicabili a qualsiasi sito web
Giulio Coraggio196 views
New Italian rules on accessibility of websites by Giulio Coraggio
New Italian rules on accessibility of websitesNew Italian rules on accessibility of websites
New Italian rules on accessibility of websites
Giulio Coraggio323 views
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022 by Giulio Coraggio
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022
Giulio Coraggio552 views
DOP, Marchi Collettivi e Marchi Storici: forme di tutela delle eccellenze by Giulio Coraggio
DOP, Marchi Collettivi e Marchi Storici: forme di tutela delle eccellenzeDOP, Marchi Collettivi e Marchi Storici: forme di tutela delle eccellenze
DOP, Marchi Collettivi e Marchi Storici: forme di tutela delle eccellenze
Giulio Coraggio319 views
Le modifiche del Codice del Consumo, come impattano sulle aziende by Giulio Coraggio
Le modifiche del Codice del Consumo, come impattano sulle aziendeLe modifiche del Codice del Consumo, come impattano sulle aziende
Le modifiche del Codice del Consumo, come impattano sulle aziende
Giulio Coraggio405 views
Good practices and common pitfalls on advertising of tobacco products in Italy by Giulio Coraggio
Good practices and common pitfalls on advertising of tobacco products in ItalyGood practices and common pitfalls on advertising of tobacco products in Italy
Good practices and common pitfalls on advertising of tobacco products in Italy
Giulio Coraggio1.6K views
Good practices and common pitfalls on advertising of alcoholic products in Italy by Giulio Coraggio
Good practices and common pitfalls on advertising of alcoholic products in ItalyGood practices and common pitfalls on advertising of alcoholic products in Italy
Good practices and common pitfalls on advertising of alcoholic products in Italy
Giulio Coraggio4.5K views
Infografica - Misure di protezione CSIRT contro rischi di cyber derivanti dal... by Giulio Coraggio
Infografica - Misure di protezione CSIRT contro rischi di cyber derivanti dal...Infografica - Misure di protezione CSIRT contro rischi di cyber derivanti dal...
Infografica - Misure di protezione CSIRT contro rischi di cyber derivanti dal...
Giulio Coraggio246 views
Italian Gambling Advertising Ban – Don'ts and Do's by Giulio Coraggio
Italian Gambling Advertising Ban – Don'ts and Do'sItalian Gambling Advertising Ban – Don'ts and Do's
Italian Gambling Advertising Ban – Don'ts and Do's
Giulio Coraggio2.1K views
Good practices and common pitfalls on ESG advertising in Italy by Giulio Coraggio
Good practices and common pitfalls on ESG advertising in ItalyGood practices and common pitfalls on ESG advertising in Italy
Good practices and common pitfalls on ESG advertising in Italy
Giulio Coraggio486 views
Come gestire gli obblighi privacy di un attacco ransomware by Giulio Coraggio
Come gestire gli obblighi privacy di un attacco ransomwareCome gestire gli obblighi privacy di un attacco ransomware
Come gestire gli obblighi privacy di un attacco ransomware
Giulio Coraggio192 views
Intelligenza artificiale: le sue potenzialità, la bozza di regolamento UE e r... by Giulio Coraggio
Intelligenza artificiale: le sue potenzialità, la bozza di regolamento UE e r...Intelligenza artificiale: le sue potenzialità, la bozza di regolamento UE e r...
Intelligenza artificiale: le sue potenzialità, la bozza di regolamento UE e r...
Giulio Coraggio590 views
Come gestire un data breach da attacco ransomware by Giulio Coraggio
Come gestire un data breach da attacco ransomwareCome gestire un data breach da attacco ransomware
Come gestire un data breach da attacco ransomware
Giulio Coraggio289 views
Trasferimento dei dati extra SEE dopo Schrems II e le nuove SCC by Giulio Coraggio
Trasferimento dei dati extra SEE dopo Schrems II e le nuove SCCTrasferimento dei dati extra SEE dopo Schrems II e le nuove SCC
Trasferimento dei dati extra SEE dopo Schrems II e le nuove SCC
Giulio Coraggio369 views
Marketing, CRM e Social Media dopo le decisioni del Garante privacy e dell'EDPB by Giulio Coraggio
Marketing, CRM e Social Media dopo le decisioni del Garante privacy e dell'EDPBMarketing, CRM e Social Media dopo le decisioni del Garante privacy e dell'EDPB
Marketing, CRM e Social Media dopo le decisioni del Garante privacy e dell'EDPB
Giulio Coraggio95 views
Come valutare l'adeguatezza dei trasferimenti di dati extra SEE dopo la sente... by Giulio Coraggio
Come valutare l'adeguatezza dei trasferimenti di dati extra SEE dopo la sente...Come valutare l'adeguatezza dei trasferimenti di dati extra SEE dopo la sente...
Come valutare l'adeguatezza dei trasferimenti di dati extra SEE dopo la sente...
Giulio Coraggio272 views
I controlli sui dipendenti durante l'emergenza covid-19 by Giulio Coraggio
I controlli sui dipendenti durante l'emergenza covid-19 I controlli sui dipendenti durante l'emergenza covid-19
I controlli sui dipendenti durante l'emergenza covid-19
Giulio Coraggio300 views

Recently uploaded

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP by
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPMohamadAlhes
110 views28 slides
Calcutta Clinical Course - Allen College of Homoeopathy by
Calcutta Clinical Course - Allen College of HomoeopathyCalcutta Clinical Course - Allen College of Homoeopathy
Calcutta Clinical Course - Allen College of HomoeopathyAllen College
98 views32 slides
Vyadhikshmatva.pptx 1.pptx by
Vyadhikshmatva.pptx 1.pptxVyadhikshmatva.pptx 1.pptx
Vyadhikshmatva.pptx 1.pptxAkshay Shetty
57 views29 slides
Obesity.pdf by
Obesity.pdfObesity.pdf
Obesity.pdfRutvikunvar Raualji (PT)
147 views30 slides
puravive ingredients.pdf by
puravive ingredients.pdfpuravive ingredients.pdf
puravive ingredients.pdfmargamharshitha062
11 views1 slide
Trustlife Türkiye - Güncel Platform Yapısı by
Trustlife Türkiye - Güncel Platform YapısıTrustlife Türkiye - Güncel Platform Yapısı
Trustlife Türkiye - Güncel Platform YapısıTrustlife
48 views2 slides

Recently uploaded(20)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP by MohamadAlhes
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
MohamadAlhes110 views
Calcutta Clinical Course - Allen College of Homoeopathy by Allen College
Calcutta Clinical Course - Allen College of HomoeopathyCalcutta Clinical Course - Allen College of Homoeopathy
Calcutta Clinical Course - Allen College of Homoeopathy
Allen College98 views
Trustlife Türkiye - Güncel Platform Yapısı by Trustlife
Trustlife Türkiye - Güncel Platform YapısıTrustlife Türkiye - Güncel Platform Yapısı
Trustlife Türkiye - Güncel Platform Yapısı
Trustlife48 views
Adverse Drug Reactions by NAKUL DHORE
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
NAKUL DHORE23 views
Gastro-retentive drug delivery systems.pptx by ABG
Gastro-retentive drug delivery systems.pptxGastro-retentive drug delivery systems.pptx
Gastro-retentive drug delivery systems.pptx
ABG238 views
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad by Swetha rani Savala
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
The Art of naming drugs.pptx by DanaKarem1
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptx
DanaKarem127 views
Explore new Frontiers in Medicine with AI.pdf by Anne Marie
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
Anne Marie20 views

Good practices and common pitfalls on advertising of medicines in Italy

  • 1. #4 Good practices and common pitfalls on promotion of medicines in Italy Advertising in Italy: DOs and DON'Ts
  • 2. ·Promote to healthcare professionals all kinds of authorized medicines ·Request the authorization for promotional materials addressed to the general public ·File with the Italian Medicines Agency (AIFA) promotional materials addressed to healthcare professionals Efficacy Claims General Rules ·Promote medicines that have not been granted a marketing authorization ·Do any misleading promotion ·Promote exclusively or principally at children
  • 3. Content of the promotional message ·Include information compliant with the summary of product characteristics ·Encourage the rational use of the medicinal product, by presenting it objectively and without exaggerating its properties ·Make it clear that the message is an advertisement ·Clearly identify the product as a medicinal product
  • 4. ·Distribute samples of medicinal products ·Promote prescription-only medicines ·Promote reimbursed medicines ·Promote medicinal products containing narcotics ·Promote products intended for use with the intervention of HCPs ·Use claims that can lead to excessive, improper or inappropriate use of medicinal products When addressing the general public